BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8747056)

  • 1. A paradoxical inhibition of androgenic hyperproduction by a Sertoli-Leydig cell tumour ovary.
    Amato G; Izzo G; Izzo A
    Hum Reprod; 1995 Nov; 10(11):2967-9. PubMed ID: 8747056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sertoli-Leydig cell tumor of the ovary producing alpha-fetoprotein.
    Chumas JC; Rosenwaks Z; Mann WJ; Finkel G; Pastore J
    Int J Gynecol Pathol; 1984; 3(2):213-9. PubMed ID: 6208158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sertoli-Leydig cell tumor of the ovary: a rare cause of amenorrhea.
    Larsen WG; Felmar EA; Wallace ME; Frieder R
    Obstet Gynecol; 1992 May; 79(5 ( Pt 2)):831-3. PubMed ID: 1565381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AFP-producing Sertoli-Leydig cell tumor of the ovary.
    Sekiya S; Inaba N; Iwasawa H; Kobayashi O; Takamizawa H; Matsuzaki O; Nagao K
    Arch Gynecol; 1985; 236(3):187-96. PubMed ID: 2409934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An unusual hormone pattern in a virilized woman affected by Sertoli-Leydig cell tumor. Report of a case.
    Satta MA; De Rosa G; Scoppola A; Rabitti C; Piccinno E; Monaco F
    Acta Pathol Jpn; 1989 Nov; 39(11):755-8. PubMed ID: 2694756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sertoli-Leydig-cell ovarian tumor with a retiform pattern and heterologous elements: a rare cause of virilization].
    García Pascual IJ; Corrales Hernández JJ; Miralles García JM; García Díez LC; Villabona Sánchez V; Serrano de Dios E
    Rev Clin Esp; 1992 Mar; 190(4):191-4. PubMed ID: 1589616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An immunohistological study of steroid localization in Sertoli-Leydig tumors of the ovary and testis.
    Kurman RJ; Andrade D; Goebelsmann U; Taylor CR
    Cancer; 1978 Oct; 42(4):1772-83. PubMed ID: 361211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct in-vivo detection of atypical hormonal expression of a Sertoli-Leydig cell tumour following stimulation with human chorionic gonadotrophin.
    Cohen I; Shapira M; Cuperman S; Goldberger S; Siegal A; Altaras M; Beyth Y
    Clin Endocrinol (Oxf); 1993 Oct; 39(4):491-5. PubMed ID: 8287578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sertoli-Leydig cell tumor of the ovary, with an associated mucinous cystadenoma. An ultrastructural and endocrine study.
    Roth LM; Cleary RE; Rosenfield RL
    Lab Invest; 1974 Dec; 31(6):648-57. PubMed ID: 4280005
    [No Abstract]   [Full Text] [Related]  

  • 10. Ovarian Sertoli-Leydig cell tumor with retiform and heterologous components. Report of a case with hepatocytic differentiation and elevated serum alpha-fetoprotein.
    Young RH; Perez-Atayde AR; Scully RE
    Am J Surg Pathol; 1984 Sep; 8(9):709-18. PubMed ID: 6206735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Well-differentiated ovarian Sertoli-Leydig cell tumors: a clinicopathological analysis of 23 cases.
    Young RH; Scully RE
    Int J Gynecol Pathol; 1984; 3(3):277-90. PubMed ID: 6500802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid biosynthesis in the Sertoli-Leydig cell tumor: effects of insulin and luteinizing hormone.
    Nagamani M; Stuart CA; Van Dinh T
    Am J Obstet Gynecol; 1989 Dec; 161(6 Pt 1):1738-43. PubMed ID: 2532472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virilising ovarian tumour: a case associating a Sertoli-Leydig cell tumour and a Brenner tumour.
    Persechini ML; Motton S; Leguevaque P; Donadille F; Escourrou G; Vierasu B; Hamdi S; Bennet A; Caron P
    Gynecol Endocrinol; 2011 May; 27(5):345-50. PubMed ID: 20569103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of immunoreactive inhibin by a virilizing ovarian tumour (Sertoli-Leydig tumour).
    Ohashi M; Hasegawa Y; Haji M; Igarashi M; Nawata H
    Clin Endocrinol (Oxf); 1990 Nov; 33(5):613-8. PubMed ID: 2253412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pure leydig cell tumour of the ovary in a post-menopausal patient with severe hyperandrogenism and erythrocytosis.
    Yetkin DO; Demirsoy ET; Kadioglu P
    Gynecol Endocrinol; 2011 Apr; 27(4):237-40. PubMed ID: 20518640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of alpha-fetoprotein production by Sertoli-Leydig cell tumors of the ovary: an immunohistochemical study of eight cases.
    Gagnon S; Têtu B; Silva EG; McCaughey WT
    Mod Pathol; 1989 Jan; 2(1):63-7. PubMed ID: 2466289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sertoli-Leydig cell tumour (arrhenoblastoma) in a patient with polycystic ovary syndrome: clinical, ultrasonographic, hormonal and histopathological evaluation].
    Puzigaća S; Prelević G; Svetenović Z; Djuricić S; Kokan Dj; Radivojević U
    Srp Arh Celok Lek; 2001; 129 Suppl 1():51-5. PubMed ID: 15637992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of ovarian Sertoli-Leydig cell tumor associated with high serum alpha-fetoprotein (AFP) concentration].
    Ohyama N; Yamamoto Y; Tanaka K; Fujimori R; Yanase T; Igarashi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Jun; 42(6):637-40. PubMed ID: 1698212
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of selective venous catheterization in localizing a small androgen-producing tumor in ovary.
    Nishiyama S; Hirota Y; Udagawa Y; Kato R; Hayakawa N; Tukada K
    Med Sci Monit; 2008 Feb; 14(2):CS9-12. PubMed ID: 18227769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Endocrine functional ovarian tumor].
    Tamaya T
    Nihon Rinsho; 2006 Jun; Suppl 2():361-5. PubMed ID: 16817422
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.